Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology. (link.springer.com)

Authors: Wakerell S … Kote-Jarai Z Journal: Genome Medicine Published: 2026-04-18 DOI: https://doi.org/10.1186/s13073-026-01640-y